Abstract
ObjectivesTo evaluate the effect of four-phase national lockdown from March 25 to May 31 in response to the COVID-19 pandemic in India and unmask the state-wise variations in terms of multiple public health metrics.DesignCohort study (daily time series of case counts).SettingObservational and population based.ParticipantsConfirmed COVID-19 cases nationally and across 20 states that accounted for >99% of the current cumulative case counts in India until 31 May 2020.ExposureLockdown (non-medical intervention).Main outcomes and measuresWe illustrate the masking of state-level trends and highlight the variations across states by presenting evaluative evidence on some aspects of the COVID-19 outbreak: case fatality rates, doubling times of cases, effective reproduction numbers and the scale of testing.ResultsThe estimated effective reproduction number R for India was 3.36 (95% CI 3.03 to 3.71) on 24 March, whereas the average of estimates from 25 May to 31 May stands at 1.27 (95% CI 1.26 to 1.28). Similarly, the estimated doubling time across India was at 3.56 days on 24 March, and the past 7-day average for the same on 31 May is 14.37 days. The average daily number of tests increased from 1717 (19–25 March) to 113 372 (25–31 May) while the test positivity rate increased from 2.1% to 4.2%, respectively. However, various states exhibit substantial departures from these national patterns.ConclusionsPatterns of change over lockdown periods indicate the lockdown has been partly effective in slowing the spread of the virus nationally. However, there exist large state-level variations and identifying these variations can help in both understanding the dynamics of the pandemic and formulating effective public health interventions. Our framework offers a holistic assessment of the pandemic across Indian states and union territories along with a set of interactive visualisation tools that are daily updated at covind19.org.
Funder
University of Michigan Precision Health Initiative
Michigan Institute of Data Science
National Cancer Institute
University of Michigan Institute for Health Care Policy and Innovation
School of Public Health, University of Michigan
University of Michigan Rogel Cancer Center
Reference41 articles.
1. Mayo Foundation for Medical Education and Research . Coronavirus disease 2019 (COVID- 19)—Symptoms and causes. Mayo Clinic, 2020. Available: https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963
2. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
3. Chauhan N . After Covid-19 lockdown, plan to unlock India in phases, 2020.
4. Government of India, Ministry of Home Affairs . D.O. No. 40-3/2020-DM-I(A); 2020.
5. COVID-19 India . COVID-19 Tracker updates for India for State-wise and District-wise data, 2020. Available: https://www.covid19india.org/
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献